Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Delirium 

Delirium
Chapter:
Delirium
Author(s):

Kotaro Hatta

DOI:
10.1093/med/9780190929671.003.0024
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 31 July 2021

The fundamental concept of delirium is altered consciousness and its fluctuation. Sleep–wake cycle disturbance is one of the common clinical features of delirium. Evidence suggests that disturbed sleep plays a key role in pathogenesis of delirium and restoration of sleep–wake cycle provides a clinical opportunity for prevention of delirium. It is essential to evaluate clinical factors such as medical illnesses, psychiatric disorders, substance use disorders, medication side effects, and environmental factors leading to sleep disturbance in delirium. In addition, multicomponent nonpharmacologic delirium prevention interventions are effective in reducing delirium incidence and preventing falls, with trend toward decreasing length of stay, but nonsignificant reductions in mortality. Approaches to regulating functions of melatonin or orexin on sleep–wake cycle lead to pharmacological interventions, and preventive effects of melatonin receptor agonists and an orexin receptor antagonist on delirium have been shown. This evidence suggests importance of treating sleep–wake cycle disturbance to prevent delirium. More research is warranted to develop comprehensive clinical strategies, targeting sleep disturbance to predict, prevent and treat delirium.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.